Natural products targeting cancer cell dependency

Area of Science:

• Oncology
• Genomics
• Pharmacology

Background:

• Precision cancer medicine currently focuses on targeting oncogenes.
• Defective tumor suppressors are challenging drug targets.
• Synthetic lethality exploits cancer-specific dependencies arising from tumor suppressor loss.

Purpose of the Study:

• To review advances in discovering natural products for synthetic lethality in cancer.
• To discuss the potential of natural products in precision cancer medicine.

Main Methods:

• Review of literature on synthetic lethality and natural product drug discovery.
• Analysis of large-scale screening methods (RNAi, CRISPR/Cas9) for synthetic lethal partners.
• Exploration of natural products as sources for pharmacologically active small molecules.

Main Results:

• Synthetic lethality, exemplified by BRCA-PARP inhibitors, is a validated therapeutic strategy.
• Large-scale screenings have identified synthetic lethal partners for tumor suppressors.
• Natural products represent an underexplored resource for synthetic lethal drug discovery.

Conclusions:

• Natural products hold significant potential for developing novel synthetic lethal therapies.
• Further research into natural products can expand therapeutic options in precision cancer medicine.